Gujarat Kidney & Super Speciality Ltd Share Price

Hospitals / Medical ServicesNSE
₹149.28
-1.27-0.84% (1D)
As on 20 Nov 2026 at 15:54
As of 20 Nov 2026 at 15:54, Gujarat Kidney & Super Speciality Ltd is trading at ₹149.28. The 52-week range stands at ₹98.25–₹210.20, with a market cap of ₹1.17 thousand crore. At a P/E of 156.42 and a dividend yield of 0.00%, it is a small-cap stock in the Healthcare sector.

GKSL Price Chart

Market Cap
₹1.17K Cr
PE Ratio
156.42
ROCE
3.87%

Gujarat Kidney & Super Speciality Ltd Performance

Gujarat Kidney & Super Speciality Ltd Fundamentals

Know More
Market Cap₹1.17K Cr
ROE3.00%
P/E Ratio (TTM)156.42
EPS (TTM)₹0.95
P/B Ratio4.68
Dividend Yield0.00%
Industry P/E188.26
Book Value₹31.73
Debt to Equity0.06
Face Value₹2

Gujarat Kidney & Super Speciality Ltd Shareholding Pattern

Know More
Promoter71.5%
Foreign Institutions6.5%
Mutual Funds0%
Domestic Institutions0.3%
Public21.8%

Gujarat Kidney & Super Speciality Ltd Financial Statements

Know More
No data for this view.

Gujarat Kidney & Super Speciality Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹9,190.05
452.05(+5.17%)
1,32,138.86,696.5 - 9,282.5
Max Healthcare Institute Ltd
₹1,079.60
38.95(+3.74%)
1,05,080.4797.0 - 1,185.4
Manipal Health Enterprises Ltd
₹702.20
5.75(+0.83%)
92,365.8597.0 - 815.0
Aster DM Quality Care Ltd
₹779.65
40.35(+5.46%)
67,959.9519.1 - 891.3
Fortis Healthcare Ltd
₹825.00
15.15(+1.87%)
62,284.1705.0 - 1,010.1

About Gujarat Kidney & Super Speciality

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad. The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care. It is one of the regional healthcare companies located in the central region of state of Gujarat. The Company categorize its healthcare services as secondary services (which are surgical services) and Tertiary Services (which are super speciality surgical services). The hospitals are providing integrated diagnostic services, either in-house, and pharmacies that cater to patients. The Company established and commenced the operations of its first hospital under the name of Gujarat Kidney Hospital' at Vadodara, Gujarat in 2014 and later on expanded the bed capacity from 15 to 65 in 2018, with the establishment of 5 sub-specialities in the Uro Department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at the Gujarat Kidney Hospital. In 2019, it set up an in-house interventional cardiology department under the name of Gujarat Heart Care Unit' for offering invasive cardiology services. In 2021, carried out its first laparoscopic radical prostatectomy at the Gujarat Kidney Hospital. The Company commenced operations of its second hospital in Godhra, Gujarat in 2023, followed by carrying its first renal transplant and first Angiography in Godhra Hospital. The Company set up 3 super-speciality departments for cardiology, urology and nephrology at the Godhra Hospital in 2023-24. In 2024, Company carried out its first retrograde intrarenal surgery (RIRS) at the Godhra Hospital. It acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it the Subsidiary of the Company. In 2025, the Company has acquired Ashwini Medical Centre and further acquired Ashwini Medical Store in 2025. It further acquired 51% of equity shares of Harmony Medicare Private Limited, making it a subsidiary in 2025. The Company launched the IPO by issuing 2,20,00,000 Equity shares of Rs 2 each and raised funds aggregating to Rs 250.80 crore through fresh issue on 24 December 2025.

Parent Organisation—
Founded2019
Managing DirectorPragnesh Bharpoda
NSE SymbolGKSL

Gujarat Kidney & Super Speciality Ltd Resistance and Support levels

R3155.24R2153.49R1152.41S1148.90S2147.82S3146.06149.28

Gujarat Kidney & Super Speciality Ltd Technicals

Current Price
₹149.28 ₹1.27 (-0.84%)
Bearish
10
Bullish
2
  • 20 Day7.7%
  • 50 Day9.7%
  • 100 Day5.3%
  • 200 Day8.8%

Gujarat Kidney & Super Speciality Ltd Latest News

View More
26 SEPT 2026 | Saturday
Gujarat Kidney halts share trading ahead of financial results announcement next quarter
27 AUG 2026 | Thursday
Gujarat Kidney management to present at GIA Healthcare Day in Mumbai on August 31
25 AUG 2026 | Tuesday
Gujarat Kidney appoints Dr. Disha Bharpoda as independent director for five years
24 AUG 2026 | Monday
Gujarat Kidney appoints Dr. Disha Bharpoda as independent director for five years
06 AUG 2026 | Thursday
Gujarat Kidney And Superspeciality Limited to review financial results at August meeting
25 MAY 2026 | Monday
Gujarat Kidney & Super Speciality to announce Quarterly Result

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Annual ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced

Frequently asked questions

The share price of Gujarat Kidney & Super Speciality Ltd is ₹149.28 as of 20 Nov 2026 at 15:54.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now